vimarsana.com

Page 4 - Vimta Labs Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vimta Labs Ltd posts consolidated PAT of Rs 13 21 crores in Q2FY23

The Board of Directors of Vimta Labs Limited, at its meeting held today have approved the financial results of the company for the period ended September 30, 2022 - Q2FY23 and H1FY23.

Worldwide Preclinical CRO Industry to 2026 - Increase in R&D Budget for Drug Development Presents Opportunities

Worldwide Preclinical CRO Industry to 2026 - Increase in R&D Budget for Drug Development Presents Opportunities

Vimta Labs Ltd reports consolidated Q2FY22 PAT of Rs 9 74 crore

Vimta Labs Ltd reports consolidated Q2FY22 PAT of Rs 9 74 crore
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Vimta Labs Ltd Q1FY22 consolidated net profit rises to Rs 8 07 crore

Vimta Labs Ltd Q1FY22 consolidated net profit rises to Rs 8 07 crore
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.